← All companies
CRISPR Therapeutics AG
CRSP - Company ID 0001674416
Market cap$5.38 B
Rank#1365
Filings837
Market capitalization of CRISPR Therapeutics AG
As of 2026-09-07, CRISPR Therapeutics AG (CRSP) has a market capitalization of $5.38 B, making it the #1365 most valuable US-listed company.
Recent market cap readings
| Date | Market cap |
|---|---|
| 2026-09-07 | $5.38 B |
| 2026-09-06 | $5.38 B |
| 2026-09-05 | $5.38 B |
| 2026-09-04 | $5.38 B |
| 2026-09-03 | $5.42 B |
| 2026-09-02 | $5.49 B |
| 2026-09-01 | $5.48 B |
| 2026-08-31 | $5.50 B |
| 2026-08-30 | $5.57 B |
| 2026-08-29 | $5.57 B |
| 2026-08-28 | $5.52 B |
| 2026-08-27 | $5.73 B |
Market Cap of similar companies
Frequently asked questions
What is CRISPR Therapeutics AG's market cap?
As of 2026-09-07, CRISPR Therapeutics AG (CRSP) has a market capitalization of $5.38 B, making it the #1365 most valuable US-listed company.
Where does CRISPR Therapeutics AG rank by market cap?
CRISPR Therapeutics AG is the #1365 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.